Table 3

Effect of TXA on new and progressive haemorrhage

TXA groupPlacebo groupRR (95% CI) unadjustedP value
(two-tailed)
RR (95% CI) adjusted*P value
(two-tailed)
New haemorrhage
 ≤3 hours since injury108/261 (41%)129/284 (45%)0.91 (0.75 to 1.10)0.340.89 (0.73 to 1.08)0.22
 >3 hours since injury36/138 (26%)45/129 (35%)0.75 (0.52 to 1.08)0.120.69 (0.48 to 0.99)0.044
 All patients144/399 (36%)174/413 (42%)0.86 (0.72 to 1.02)0.0790.85 (0.72 to 1.01)0.069
Exclude unreactive pupils (one/both)108/332 (33%)140/346 (40%)0.80 (0.66 to 0.98)0.0330.80 (0.66 to 0.98)0.030
Progressive haemorrhage
 ≤3 hours since injury76/261 (29%)88/284 (31%)0.94 (0.73 to 1.22)0.640.92 (0.72 to 1.19)0.53
 >3 hours since injury39/138 (28%)42/129 (33%)0.87 (0.60 to 1.25)0.450.86 (0.58 to 1.28)0.46
 All patients115/399 (29%)130/413 (31%)0.92 (0.74 to 1.13)0.410.91 (0.74 to 1.13)0.41
Exclude unreactive pupils (one/both)92/332 (28%)111/346 (32%)0.86 (0.69 to 1.09)0.220.87 (0.69 to 1.10)0.24
  • *Adjusted for time from injury to pre-randomisation scan, age, GlasgowComa Score, pupil reaction, systolic blood pressure and participating hospital.

  • RR, relative risk; TXA, tranexamic acid.